The effect of amantadine on radiolabeled biogenic amines in the rat brain.
D000547:Amantadine / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D001679:Biogenic Amines / Q000032:analysis / Q000378:metabolism*; D001921:Brain / Q000201:enzymology / Q000378:metabolism*; D001923:Brain Chemistry / Q000187:drug effects*; D002247:Carbon Isotopes; D002854:Chromatography, Paper; D003342:Corpus Striatum / Q000166:cytology / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000378:metabolism; D004298:Dopamine / Q000032:analysis / Q000378:metabolism; D007267:Injections; D007490:Iproniazid / Q000494:pharmacology; D008297:Male; D008995:Monoamine Oxidase / Q000032:analysis; D009638:Norepinephrine / Q000378:metabolism; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D013574:Synaptosomes / Q000378:metabolism; D014316:Tritium
D001679:Biogenic Amines; D002247:Carbon Isotopes; D014316:Tritium; D012701:Serotonin; D004295:Dihydroxyphenylalanine; D000547:Amantadine; D007490:Iproniazid; D008995:Monoamine Oxidase; D004298:Dopamine; D009638:Norepinephrine